Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. scores highest on Torque (73) and lowest on Price (0). Its PosiPenta is 46.69 out of 100, around the middle of similar companies.
On the Penta Grid this week, Seaport Therapeutics, Inc. is Grid #349 of 837 in the Healthcare sector in United States, and Grid #2,259 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Seaport Therapeutics, Inc. | 46.69 | 0 | 37 | 57 | 73 | 67 |
| Amphastar Pharmaceuticals, Inc. | 70.81 | 70 | 80 | 87 | 52 | 66 |
| Vor Biopharma Inc. | 61.13 | 48 | 53 | 63 | 92 | 49 |
| IRADIMED CORPORATION | 65.14 | 16 | 67 | 75 | 90 | 78 |
| Latigo Biotherapeutics, Inc. | 26.19 | 0 | 30 | 40 | 8 | 53 |
| STAAR Surgical Company | 55.20 | 24 | 87 | 58 | 63 | 43 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.07 |
| P/B ratio | -8.26 |
EEarnings
| Trailing EPS | ₹-550.29 |
| Forward EPS | ₹-238.81 |
NNitro
| Price | 1688.77 |
| 52-week high | 2688.01 |
| 52-week low | 1406.52 |
| Fall from 52-week high | 37.2% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹9,040 Cr |
| Insider holding | 35.14% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Seaport Therapeutics, Inc.'s PosiPenta score?
Seaport Therapeutics, Inc.'s PosiPenta is 46.69 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Seaport Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Seaport Therapeutics, Inc. is Grid #349 of 837 in the Healthcare sector in United States, and Grid #2,259 of 4,000 in United States.
Which PosiPenta pillar is strongest for Seaport Therapeutics, Inc.?
Torque (durability), with a score of 73 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Seaport Therapeutics, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Seaport Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.09 points, from 42.60 to 46.69.
PositoAI is for research and education only and is not investment advice.